The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Amlodipine besylate and Olmesartran medoxomil
Amlodipine besylate and Olmesartran medoxomil · AMLODIPINE BESYLATE 10 mg/1; OLMESARTAN MEDOXOMIL 20 mg/1 · Tablet, Film Coated · Oral · Alembic Pharmaceuticals Limited
NDC 46708-0214-30 · 30 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for amlodipine besylate and olmesartran medoxomil (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA207073
- TE code
- AB
- Approval date
- Jul 17, 2017
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Amlodipine besylate and Olmesartran medoxomil (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Alembic Pharmaceuticals Inc. | AMLODIPINE BESYLATE 10 mg/1; OLMESARTAN MEDOXOMIL 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | AMLODIPINE BESYLATE 10 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | AMLODIPINE BESYLATE 5 mg/1; OLMESARTAN MEDOXOMIL 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | AMLODIPINE BESYLATE 5 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | AMLODIPINE BESYLATE 5 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | AMLODIPINE BESYLATE 10 mg/1; OLMESARTAN MEDOXOMIL 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | AMLODIPINE BESYLATE 5 mg/1; OLMESARTAN MEDOXOMIL 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | AMLODIPINE BESYLATE 10 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Amlodipine besylate and Olmesartran medoxomil — NDC 46708-0214-30," retrieved September 3, 2026, https://drugdashboards.com/drug/46708021430.
Free to cite with attribution — see how the data is put together.